Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D001803:Blood Transfusion; D001854:Bone Marrow Cells; D001856:Bone Marrow Examination; D016026:Bone Marrow Transplantation; D003601:Cytotoxicity Tests, Immunologic; D004285:Dogs; D005260:Female; D006084:Graft Rejection; D006648:Histocompatibility; D006650:Histocompatibility Testing; D007109:Immunity / Q000187:drug effects*; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D011344:Procarbazine / Q000494:pharmacology*; D011817:Rabbits / Q000276:immunology; D011828:Radiation Chimera; D013950:Thymus Gland / Q000166:cytology; D014181:Transplantation Immunology / Q000187:drug effects*; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D011344:Procarbazine